Filed: 5/11/2023ACC: 0001104659-23-058942
📋 What this filing means
KNOTT DAVID M JR filed this quarterly 13F‑HR report disclosing 150 equity positions with a total reported market value of $254.5K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
150
Positions
$254.5K
Total AUM (reported)
16.63M
Total Shares
Allocation by class
COMMON$254.5K100.0%
Portfolio Concentration
Top 3$101.5K39.9%
4–10$61.3K24.1%
11–25$49.5K19.4%
Rest$42.2K16.6%
Top 3 weight
39.9%
Top 10 weight
64.0%
Voting Authority Distribution
Total shares with voting rights: 16.63M
Sole
Full voting authority
16.63M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other150
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings150
Rows:
Calumet Specialty Products Partners, LP
DFNDShares4.33M
TypeSH
Market value$75.2K
29.54%
Sole
4.33M
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$14.2K
5.58%
Sole
225K
Shared
0.00
None
0.00
DocGo, Inc.
DFNDShares1.40M
TypeSH
Market value$12.1K
4.76%
Sole
1.40M
Shared
0.00
None
0.00
FTAI Aviation Ltd.
DFNDShares425K
TypeSH
Market value$11.9K
4.67%
Sole
425K
Shared
0.00
None
0.00
Alphabet Inc-Cl C
DFNDShares112.22K
TypeSH
Market value$11.7K
4.59%
Sole
112.22K
Shared
0.00
None
0.00
Franklin BSP Realty Trust, Inc.
DFNDShares859.05K
TypeSH
Market value$10.2K
4.03%
Sole
859.05K
Shared
0.00
None
0.00
Ligand Pharmaceuticals Incorporated
DFNDShares115K
TypeSH
Market value$8.5K
3.32%
Sole
115K
Shared
0.00
None
0.00
Ardelyx, Inc.
DFNDShares1.50M
TypeSH
Market value$7.2K
2.82%
Sole
1.50M
Shared
0.00
None
0.00
Midwest Holding Inc.
DFNDShares390.24K
TypeSH
Market value$6.2K
2.42%
Sole
390.24K
Shared
0.00
None
0.00
Coliseum Acquisition Corp. Wts
DFNDShares495K
TypeSH
Market value$5.7K
2.24%
Sole
495K
Shared
0.00
None
0.00
African Gold Acquistion Corp. Warrants
DFNDShares450.75K
TypeSH
Market value$5.2K
2.04%
Sole
450.75K
Shared
0.00
None
0.00
Horizon Therapeutics Public Ltd. Company
DFNDShares41.49K
TypeSH
Market value$4.5K
1.78%
Sole
41.49K
Shared
0.00
None
0.00
Calumet Specialty Products Partners, LP @20 exp 1/24
DFNDShares251K
TypeSH
Market value$4.4K
1.71%
Sole
251K
Shared
0.00
None
0.00
OmniAb Inc.
DFNDShares1.09M
TypeSH
Market value$4.0K
1.57%
Sole
1.09M
Shared
0.00
None
0.00
Pfizer Inc.
DFNDShares97.54K
TypeSH
Market value$4.0K
1.56%
Sole
97.54K
Shared
0.00
None
0.00
Madrigal Pharmaaceuticals, Inc.
DFNDShares14K
TypeSH
Market value$3.4K
1.33%
Sole
14K
Shared
0.00
None
0.00
Viking Therapeutics, Inc.
DFNDShares200.16K
TypeSH
Market value$3.3K
1.31%
Sole
200.16K
Shared
0.00
None
0.00
Jazz Pharmaceuticals PLC
DFNDShares22.41K
TypeSH
Market value$3.3K
1.29%
Sole
22.41K
Shared
0.00
None
0.00
Sanofi
DFNDShares56K
TypeSH
Market value$3.0K
1.20%
Sole
56K
Shared
0.00
None
0.00
JPMorgan Chase & Co.
DFNDShares20.98K
TypeSH
Market value$2.7K
1.07%
Sole
20.98K
Shared
0.00
None
0.00
Avadel Pharmaceuticals plc
DFNDShares291.11K
TypeSH
Market value$2.7K
1.05%
Sole
291.11K
Shared
0.00
None
0.00
CTI BioPharma Corp.
DFNDShares566.49K
TypeSH
Market value$2.4K
0.93%
Sole
566.49K
Shared
0.00
None
0.00
GlaxoSmithKline plc
DFNDShares65K
TypeSH
Market value$2.3K
0.91%
Sole
65K
Shared
0.00
None
0.00
Vertex Pharmaceuticals, Inc.
DFNDShares7K
TypeSH
Market value$2.2K
0.87%
Sole
7K
Shared
0.00
None
0.00
CSX Corporation
DFNDShares70K
TypeSH
Market value$2.1K
0.82%
Sole
70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Calumet Specialty Products Partners, LPDFND | Common | 4.33M | SH | $75.2K 29.54% | 4.33M | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $14.2K 5.58% | 225K | 0.00 | 0.00 |
DocGo, Inc.DFND | Common | 1.40M | SH | $12.1K 4.76% | 1.40M | 0.00 | 0.00 |
FTAI Aviation Ltd.DFND | Common | 425K | SH | $11.9K 4.67% | 425K | 0.00 | 0.00 |
Alphabet Inc-Cl CDFND | Common | 112.22K | SH | $11.7K 4.59% | 112.22K | 0.00 | 0.00 |
Franklin BSP Realty Trust, Inc.DFND | Common | 859.05K | SH | $10.2K 4.03% | 859.05K | 0.00 | 0.00 |
Ligand Pharmaceuticals IncorporatedDFND | Common | 115K | SH | $8.5K 3.32% | 115K | 0.00 | 0.00 |
Ardelyx, Inc.DFND | Common | 1.50M | SH | $7.2K 2.82% | 1.50M | 0.00 | 0.00 |
Midwest Holding Inc.DFND | Common | 390.24K | SH | $6.2K 2.42% | 390.24K | 0.00 | 0.00 |
Coliseum Acquisition Corp. WtsDFND | Common | 495K | SH | $5.7K 2.24% | 495K | 0.00 | 0.00 |
African Gold Acquistion Corp. WarrantsDFND | Common | 450.75K | SH | $5.2K 2.04% | 450.75K | 0.00 | 0.00 |
Horizon Therapeutics Public Ltd. CompanyDFND | Common | 41.49K | SH | $4.5K 1.78% | 41.49K | 0.00 | 0.00 |
Calumet Specialty Products Partners, LP @20 exp 1/24DFND | Common | 251K | SH | $4.4K 1.71% | 251K | 0.00 | 0.00 |
OmniAb Inc.DFND | Common | 1.09M | SH | $4.0K 1.57% | 1.09M | 0.00 | 0.00 |
Pfizer Inc.DFND | Common | 97.54K | SH | $4.0K 1.56% | 97.54K | 0.00 | 0.00 |
Madrigal Pharmaaceuticals, Inc.DFND | Common | 14K | SH | $3.4K 1.33% | 14K | 0.00 | 0.00 |
Viking Therapeutics, Inc.DFND | Common | 200.16K | SH | $3.3K 1.31% | 200.16K | 0.00 | 0.00 |
Jazz Pharmaceuticals PLCDFND | Common | 22.41K | SH | $3.3K 1.29% | 22.41K | 0.00 | 0.00 |
SanofiDFND | Common | 56K | SH | $3.0K 1.20% | 56K | 0.00 | 0.00 |
JPMorgan Chase & Co.DFND | Common | 20.98K | SH | $2.7K 1.07% | 20.98K | 0.00 | 0.00 |
Avadel Pharmaceuticals plcDFND | Common | 291.11K | SH | $2.7K 1.05% | 291.11K | 0.00 | 0.00 |
CTI BioPharma Corp.DFND | Common | 566.49K | SH | $2.4K 0.93% | 566.49K | 0.00 | 0.00 |
GlaxoSmithKline plcDFND | Common | 65K | SH | $2.3K 0.91% | 65K | 0.00 | 0.00 |
Vertex Pharmaceuticals, Inc.DFND | Common | 7K | SH | $2.2K 0.87% | 7K | 0.00 | 0.00 |
CSX CorporationDFND | Common | 70K | SH | $2.1K 0.82% | 70K | 0.00 | 0.00 |
Page 1 of 6
…